Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuye Qinghuo Tablets is a traditional Chinese medicine (TCM) formulation developed and marketed by Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd. The drug is administered orally in tablet form and is categorized as a 'Qinghuo' (heat-clearing) preparation. In the context of TCM, such formulations are typically used to treat conditions associated with 'internal fire' or 'heat,' which often manifest as inflammation, sore throat, mouth ulcers, or gingivitis. Anhui Jiuhua Huayuan Pharmaceutical is recognized as a high-tech enterprise and a top 100 TCM company in China. While the specific herbal composition and molecular targets are not detailed in English-language clinical databases, the product is approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yuye Qinghuo Tablets.